Sonic hedgehog signaling in basal cell carcinomas.

Area of Science:

• Oncology
• Dermatology
• Molecular Biology

Background:

• Basal cell carcinoma (BCC) is the most common human cancer in fair-skinned populations.
• Constitutive activation of sonic hedgehog (SHH) signaling is a known driver of BCC development.
• Germline mutations in the PATCHED (PTCH) gene, a regulator of SHH signaling, are implicated in nevoid basal cell carcinoma syndrome.

Purpose of the Study:

• To investigate the molecular mechanisms underlying basal cell carcinoma genesis.
• To identify key genetic alterations in the hedgehog signaling pathway contributing to sporadic and UV-induced BCC.
• To explore potential therapeutic strategies for BCC based on pathway dysregulation.

Main Methods:

• Analysis of tumor suppressor gene PATCHED (PTCH) mutations in BCC.
• Investigation of proto-oncogene SMOOTHENED (SMO) and SONIC HEDGEHOG (SHH) mutations in sporadic BCC and in patients with xeroderma pigmentosum.
• Molecular analysis of hedgehog signaling pathway alterations.

Main Results:

• Germline mutations in PTCH were identified in nevoid basal cell carcinoma syndrome.
• Mutational inactivation of PTCH and gain-of-function mutations in SMO and SHH were found in sporadic BCC and UV-exposed tumors.
• These alterations lead to constitutive activation of the hedgehog signaling pathway.

Conclusions:

• Aberrant hedgehog signaling, driven by genetic mutations in PTCH, SMO, and SHH, is central to basal cell carcinoma development.
• Solar UV exposure is associated with specific mutations that activate this pathway.
• Understanding these molecular mechanisms opens avenues for targeted BCC therapies.